You are here

Article info

Article menu

Download PDFPDF

Ovarian cancer
281 Real-world-data on platinum outcomes after parp inhibitors progression in high grade serous ovarian cancer patients
Free

Authors

  • Andrea Plaja Salarich Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip); Badalona-Applied Research Group in Oncology (B-Argo); Medical Oncology Department PubMed articlesGoogle scholar articles
  • Iris Teruel García Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip); Badalona-Applied Research Group in Oncology (B-Argo); Medical Oncology Department PubMed articlesGoogle scholar articles
  • Beatriz Pardo Burdalo Catalan Institute of Oncology (Ico)-Idibell, L’hospitalet; Medical Oncology Department PubMed articlesGoogle scholar articles
  • Marta Gil-Martin Catalan Institute of Oncology (Ico)-Idibell, L’hospitalet; Medical Oncology Department PubMed articlesGoogle scholar articles
  • Josep Maria Piulats Rodriguez Catalan Institute of Oncology (Ico)-Idibell, L’hospitalet; Medical Oncology Department PubMed articlesGoogle scholar articles
  • Claudia Fina Planas Catalan Institute of Oncology (Ico)-Girona, Girona Biomedical Research Institute (Idibgi); Medical Oncology Department PubMed articlesGoogle scholar articles
  • María Pilar Barretina Ginesta Catalan Institute of Oncology (Ico)-Girona, Girona Biomedical Research Institute (Idibgi); Medical Oncology Department PubMed articlesGoogle scholar articles
  • Andrea Gonzalez Valencia Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip); Badalona-Applied Research Group in Oncology (B-Argo); Statistics Department PubMed articlesGoogle scholar articles
  • Anna Esteve Gomez Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip); Badalona-Applied Research Group in Oncology (B-Argo); Statistics Department PubMed articlesGoogle scholar articles
  • Margarita Romeo Marin Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip); Badalona-Applied Research Group in Oncology (B-Argo); Medical Oncology Department PubMed articlesGoogle scholar articles

Citation

Salarich AP, García IT, Burdalo BP, et al
281 Real-world-data on platinum outcomes after parp inhibitors progression in high grade serous ovarian cancer patients
International Journal of Gynecologic Cancer 2020;30:A60-A61.

Publication history

  • First published December 4, 2020.
Online issue publication 
February 04, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.